Trial Profile
A phase I trial to evaluate the safety of Nu-3 in patients with systemic infections such as complicated urinary tract infections
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 28 Jul 2014
Price :
$35
*
At a glance
- Drugs Nu 3 (Primary)
- Indications Urinary tract infections
- Focus Adverse reactions
- 28 Jul 2014 New trial record